15-Year watch begins on pioneering cystic fibrosis gene therapy
NCT ID NCT06962852
Summary
This study follows 5 people with cystic fibrosis for 15 years to monitor the long-term safety and lasting effects of a single-dose inhaled gene therapy they received in a previous trial. Participants do not receive new treatment but undergo regular health checks and lung function tests. The main goal is to watch for any delayed health problems and see if the therapy's benefits hold up over many years.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CYSTIC FIBROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
HOP Gui de Chauliac
Montpellier, 34295, France
-
Hospital Universitari Vall D Hebron
Barcelona, 08035, Spain
-
Osp. Pediatrico Bambin Gesù
Roma, 00165, Italy
-
Royal Brompton Hospital
London, SW3 6JY, United Kingdom
-
Universitair Medisch Centrum Utrecht
Utrecht, 3584 CX, Netherlands
Conditions
Explore the condition pages connected to this study.